• 1. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

Recent Advances in the Study of 4-(Allyloxy)-3,5-dichlorobenzaldehyde (CAS: 27164-07-4) in Chemical Biology and Pharmaceutical Research

The compound 4-(Allyloxy)-3,5-dichlorobenzaldehyde (CAS: 27164-07-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications in drug discovery. This research briefing aims to provide a comprehensive overview of the latest studies involving this compound, focusing on its synthesis, biological activities, and potential therapeutic applications.

Recent literature highlights the role of 4-(Allyloxy)-3,5-dichlorobenzaldehyde as a key intermediate in the synthesis of various bioactive molecules. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its utility in the development of novel antimicrobial agents. The compound's dichlorobenzaldehyde moiety was found to enhance the binding affinity of synthesized derivatives to bacterial enzymes, leading to improved efficacy against drug-resistant strains.

In addition to its antimicrobial potential, research has explored the compound's application in cancer therapeutics. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of 4-(Allyloxy)-3,5-dichlorobenzaldehyde exhibited promising inhibitory effects on specific kinase pathways involved in tumor proliferation. The allyloxy group was identified as a critical structural feature for modulating selectivity and potency.

Further investigations into the compound's mechanism of action have utilized advanced computational modeling techniques. Molecular docking studies have revealed that 4-(Allyloxy)-3,5-dichlorobenzaldehyde derivatives can interact with key amino acid residues in target proteins, providing insights for structure-activity relationship (SAR) optimization. These findings are paving the way for the design of more effective and selective drug candidates.

The safety profile and pharmacokinetic properties of 4-(Allyloxy)-3,5-dichlorobenzaldehyde derivatives have also been a focus of recent research. Toxicology studies conducted in vitro and in vivo have shown that while the compound exhibits favorable bioavailability, certain structural modifications may be necessary to reduce potential hepatotoxicity. These results underscore the importance of continued optimization in the drug development process.

Looking ahead, researchers are exploring the potential of 4-(Allyloxy)-3,5-dichlorobenzaldehyde in other therapeutic areas, including neurodegenerative diseases and inflammatory disorders. Its versatility as a chemical building block, combined with ongoing advances in synthetic methodologies, positions this compound as a valuable asset in medicinal chemistry. Future studies are expected to further elucidate its full spectrum of biological activities and therapeutic potential.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)